Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

04.09.2017

11 AIDS
4 AIDS Res Hum Retroviruses
1 Ann Intern Med
1 Curr Treat Options Neurol
3 HIV Med
2 J Acquir Immune Defic Syndr
2 J Infect Dis
1 J Med Virol
1 Lancet
2 Lancet HIV
2 Lancet Infect Dis
13 PLoS One
1 PLoS Pathog



    AIDS

  1. BOCCARA F, Ghislain M, Meyer L, Goujard C, et al
    Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from the ANRS COPANA cohort.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001633.
    >> Share

  2. FLORES HERRERA MF, Dauby N
    Eye compartmentalization of HIV replication and cataract risk in HIV-infected patients: is there a link?
    AIDS. 2017;31:2024-2025.
    >> Share

  3. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001628.
    >> Share

  4. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of postmigration HIV acquisition within nine European countries.
    AIDS. 2017;31:1979-1988.
    >> Share

  5. RUBIN LH, Cook JA, Springer G, Weber KM, et al
    Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001625.
    >> Share

  6. ORLOVA-FINK N, Chowdhury FZ, Xiaoming S, Harrington S, et al
    Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001630.
    >> Share

  7. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    >> Share

  8. MEDLAND NA, Nicholson S, Chow EPF, Read THR, et al
    Time from HIV infection to virological suppression: dramatic fall from 2007-2016.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001634.
    >> Share

  9. WEINSTEIN M, Yang OO, Cohen AC
    Were we prepared for PrEP? five years of implementation.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001626.
    >> Share

  10. RONIT A, Kristensen T, Klitbo DM, Gelpi M, et al
    Incidental lung cancers and positive computed tomography images in people living with HIV.
    AIDS. 2017;31:1973-1977.
    >> Share

  11. KLATT NR, Hunt PW
    MicroRNAs: novel tools to block gut inflammation in HIV?
    AIDS. 2017;31:2017-2018.
    >> Share


    AIDS Res Hum Retroviruses

  12. YILDIZ SEVGI D, Gunduz A, Altuntas Aydin O, Mete B, et al
    Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    AIDS Res Hum Retroviruses. 2017 Aug 30. doi: 10.1089/AID.2016.0266.
    >> Share

  13. LOEB STANGA L, Packel L, Martz T, Lemp G, et al
    The California HIV/AIDS Research Program: History, Impact, and HIV Cure Initiative.
    AIDS Res Hum Retroviruses. 2017 Aug 29. doi: 10.1089/AID.2017.0149.
    >> Share

  14. HEGEDUS A, Kavanagh Williamson M, Khan MB, Dias Zeidler J, et al
    Evidence for altered glutamine metabolism in HIV-1 infected primary human CD4+ T cells.
    AIDS Res Hum Retroviruses. 2017 Aug 26. doi: 10.1089/AID.2017.0165.
    >> Share

  15. ZHANG M, Xin R, Chang W
    A novel recombinant form of HIV-1 CRF01_AE/CRF07_BC identified by near full-length genome in Shaanxi, China.
    AIDS Res Hum Retroviruses. 2017 Aug 26. doi: 10.1089/AID.2017.0186.
    >> Share


    Ann Intern Med

  16. WALENSKY RP, Borre ED, Bekker LG, Hyle EP, et al
    Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.
    Ann Intern Med. 2017 Aug 29. doi: 10.7326/M17-1358.
    >> Share


    Curr Treat Options Neurol

  17. AZIZ-DONNELLY A, Harrison TB
    Update of HIV-Associated Sensory Neuropathies.
    Curr Treat Options Neurol. 2017;19:36.
    >> Share


    HIV Med

  18. CUZIN L, Katlama C, Cotte L, Pugliese P, et al
    Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
    HIV Med. 2017;18:395-401.
    >> Share

  19. SHEPHERD L, Borges AH, Harvey R, Bower M, et al
    The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
    HIV Med. 2017 Aug 31. doi: 10.1111/hiv.12546.
    >> Share

  20. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.
    HIV Med. 2017 Aug 29. doi: 10.1111/hiv.12539.
    >> Share


    J Acquir Immune Defic Syndr

  21. MARKOWITZ M, Grossman H, Anderson PL, Grant R, et al
    Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Aug 26. doi: 10.1097/QAI.0000000000001534.
    >> Share

  22. GOLDSTONE RN, Hasan SR, Goldstone SE
    Radiofrequency ablation therapy for anal intraepithelial neoplasia: results from a single-center prospective pilot study in HIV+ participants.
    J Acquir Immune Defic Syndr. 2017 Aug 26. doi: 10.1097/QAI.0000000000001535.
    >> Share


    J Infect Dis

  23. CLUTTER DS, Zhou S, Varghese V, Rhee SY, et al
    Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
    J Infect Dis. 2017;216:387-391.
    >> Share

  24. VAN LAARHOVEN A, Dian S, Ganiem AR, van Crevel R, et al
    Reply to Neeradi et al and Dhawan and Sankhyan.
    J Infect Dis. 2017;216:395-396.
    >> Share


    J Med Virol

  25. DEHGHANI-DEHEJ F, Sarvari J, Esghaei M, Hosseini SY, et al
    Presence of Different Hepatitis C Virus Genotypes in Plasma and Peripheral Blood Mononuclear Cell Samples of Iranian Patients with HIV Infection.
    J Med Virol. 2017 Aug 28. doi: 10.1002/jmv.24925.
    >> Share


    Lancet

  26. GREEN A
    President of Zambia declares HIV testing mandatory.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32295.
    >> Share


    Lancet HIV

  27. ROCHAT TJ, Stein A, Cortina-Borja M, Tanser F, et al
    The Amagugu intervention for disclosure of maternal HIV to uninfected primary school-aged children in South Africa: a randomised controlled trial.
    Lancet HIV. 2017 Aug 23. pii: S2352-3018(17)30133.
    >> Share

  28. CLUVER L, Sherr L
    Integrating disclosure support into family HIV care.
    Lancet HIV. 2017 Aug 23. pii: S2352-3018(17)30153.
    >> Share


    Lancet Infect Dis

  29. YOON C, Semitala FC, Atuhumuza E, Katende J, et al
    Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Lancet Infect Dis. 2017 Aug 25. pii: S1473-3099(17)30488.
    >> Share

  30. LOOKER KJ, Elmes JAR, Gottlieb SL, Schiffer JT, et al
    Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.
    Lancet Infect Dis. 2017 Aug 23. pii: S1473-3099(17)30405.
    >> Share


    PLoS One

  31. STAFYLIS C, Klausner JD
    Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection.
    PLoS One. 2017;12:e0183944.
    >> Share

  32. MWAU M, Bwana P, Kithinji L, Ogollah F, et al
    Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years.
    PLoS One. 2017;12:e0183860.
    >> Share

  33. PORTES SAR, Carvalho-Costa FA, Rocha MS, Fumian TM, et al
    Enteric viruses in HIV-1 seropositive and HIV-1 seronegative children with diarrheal diseases in Brazil.
    PLoS One. 2017;12:e0183196.
    >> Share

  34. RASHIDIAN H, Hadji M, Marzban M, Gholipour M, et al
    Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients.
    PLoS One. 2017;12:e0183017.
    >> Share

  35. SUMANKUURO J, Crockett J, Wang S
    Maternal health care initiatives: Causes of morbidities and mortalities in two rural districts of Upper West Region, Ghana.
    PLoS One. 2017;12:e0183644.
    >> Share

  36. MASSON JJR, Murphy AJ, Lee MKS, Ostrowski M, et al
    Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.
    PLoS One. 2017;12:e0183931.
    >> Share

  37. MUNOZ-MORENO JA, Prats A, Molto J, Garolera M, et al
    Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.
    PLoS One. 2017;12:e0182547.
    >> Share

  38. NANCE N, Pendo P, Masanja J, Ngilangwa DP, et al
    Short-term effectiveness of a community health worker intervention for HIV-infected pregnant women in Tanzania to improve treatment adherence and retention in care: A cluster-randomized trial.
    PLoS One. 2017;12:e0181919.
    >> Share

  39. JIAO B, Rosen Z, Bellanger M, Belkin G, et al
    The cost-effectiveness of PHQ screening and collaborative care for depression in New York City.
    PLoS One. 2017;12:e0184210.
    >> Share

  40. ANDREATOS N, Grigoras C, Shehadeh F, Pliakos EE, et al
    The impact of HIV infection and socioeconomic factors on the incidence of gonorrhea: A county-level, US-wide analysis.
    PLoS One. 2017;12:e0183938.
    >> Share

  41. AGOLORY SG, Auld AF, Odafe S, Shiraishi RW, et al
    High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    PLoS One. 2017;12:e0183823.
    >> Share

  42. LIU H, Shen W, Shu J, Kou Z, et al
    A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.
    PLoS One. 2017;12:e0184207.
    >> Share

  43. MORSICA G, Bagaglio S, Spagnuolo V, Castagna A, et al
    Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    PLoS One. 2017;12:e0184128.
    >> Share


    PLoS Pathog

  44. HOTTER D, Krabbe T, Reith E, Gawanbacht A, et al
    Primate lentiviruses use at least three alternative strategies to suppress NF-kappaB-mediated immune activation.
    PLoS Pathog. 2017;13:e1006598.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016